Related references
Note: Only part of the references are listed.Diabetes and Ischemic Heart Disease Death in People Age 25-54: A Multiple-Cause-of-Death Analysis Based on Over 400 000 Deaths From 1990 to 2008 in New York City
Adriana Quinones et al.
CLINICAL CARDIOLOGY (2015)
Clinical Diagnosis and Management of Hypertension Compared With the Joint National Committee 8 Panelists' Recommendations
David Snipelisky et al.
CLINICAL CARDIOLOGY (2015)
The Influence of Type 2 Diabetes on Left Atrial Remodeling
Marijana Tadic et al.
CLINICAL CARDIOLOGY (2015)
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
Benjamin M. Leon et al.
WORLD JOURNAL OF DIABETES (2015)
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease
Iris I. Mueller et al.
ATHEROSCLEROSIS (2014)
Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival
Iris I. Mueller et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2013)
Gremlin-1 Is an Inhibitor of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerotic Plaque Growth in ApoE-/- Mice
Iris Mueller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response
Iris I. Mueller et al.
PLOS ONE (2012)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease
Karin Mueller et al.
ATHEROSCLEROSIS (2010)
Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment
Christian Weber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2008)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Platelets in inflammation and atherogenesis
M Gawaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The expression of macrophage migration inhibitory factor 1 alpha (MIF 1 alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability
A Schmeisser et al.
ATHEROSCLEROSIS (2005)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Macrophage migration inhibitory factor: A regulator of innate immunity
T Calandra et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Engagement of glycoprotein IIb/IIIa (αIIbβ3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells
AE May et al.
CIRCULATION (2002)
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease
HQ Lue et al.
MICROBES AND INFECTION (2002)
MIF regulates innate immune responses through modulation of Toll-like receptor 4
T Roger et al.
NATURE (2001)
Share Paper
